Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma.
Motohiro FujiwaraWataru ShimadaMinato YokoyamaAnri KoyanagiHiroshi ShintakuShohei FukudaYuma WasedaHajime TanakaSoichiro YoshidaYasuhisa FujiiPublished in: IJU case reports (2024)
This is the first report of nivolumab rechallenge in metastatic renal cell carcinoma. Although the utility remains unclear, this case suggests that some patients may benefit from nivolumab rechallenge.